Score

The whole plan,
in one number.

Drug-PIN scores a patient’s complete medication plan against their laboratory values, genotype, diagnoses and age. Drug against drug is only part of it. The total is the plain sum of four sub-scores, and the conflicts that produced each one are listed underneath it. A normalised figure sits beside the total, for comparing one patient with another or with themselves over time.

Total score

220

Normalised

60 / 200

Moderate
Excellent Moderate Poor

Illustrative figures, for a plan of 11 medications. The total here is 147 + 38 + 20 + 15, and has no fixed upper bound. The normalised score rescales it against patients on the same number of medications, onto a 1–200 scale.

What contributes

Four sub-scores add up to the total.

Nothing else is added. Everything else Drug-PIN shows is context for these four.

Interactions

A severity-weighted sum of the drug–drug interactions in the plan. One severe interaction contributes more than several mild ones, so a count alone would mislead.

Metabolism & genetics

The metabolic load of the whole plan across CYP enzymes and transporters, together with mismatches between the patient’s pharmacogenomic variants and the drugs they are taking.

PRISCUS

Potentially inappropriate medication in older patients, from the German PRISCUS list, which applies from age 65.

The European EU(7)-PIM list is evaluated and shown alongside it, but is not added to the total.

Kidney

Derived from eGFR and weighted by the patient’s stage of renal impairment, plus drugs that are specifically inadvisable at that level of kidney function.

The score tab in Drug-PIN. A total score of 220.00 with a normalised score of 60.40 of 200,
           above four cards for the contributing sub-scores (metabolism and genetics 38, interactions
           147, kidney 15 and PRISCUS 20), and a separate row of supporting metrics below them.
The four contributing sub-scores, and the supporting metrics kept apart from them.

Supporting metrics

Shown for context. They stay outside the total.

These feed the four sub-scores above. They are displayed on their own so you can see what drove a number. Adding them yourself would double-count.

QTc

Drug-induced QT prolongation, against age- and sex-specific thresholds.

Albumin

Free-drug levels in hypoalbuminaemia, by protein-binding profile.

Age

Paediatric or geriatric cautions triggered by this patient’s age.

Weight

Weight- and BMI-based cautions where a weight-dependent drug is in the plan.

ICD-10

Drug–disease conflicts, such as an NSAID with active GI bleeding.

Enzyme load

How strongly the plan as a whole loads each CYP enzyme and transporter.

eGFR

Drugs flagged at this filtration rate.

Q₀ liver & kidney

Accumulation risk from impaired hepatic or renal clearance.

The conflicts

Every point traces back to something you can read.

The total is not a verdict handed down. Underneath it is the list it was built from: each interacting pair, how severe it is, the mechanism in a sentence, and the published evidence behind it. A score can be checked.

The detected-conflict list in Drug-PIN. Six interactions are listed, headed by a severity X
           conflict between clarithromycin and simvastatin, then severity D conflicts for amitriptyline
           with tramadol and furosemide with ramipril. Each card carries a plain-language explanation of
           the mechanism and one or more PubMed identifiers.
Six of the interactions found in this plan, with severity, mechanism and sources.

Changing the plan

Alternatives are candidates for you to weigh.

The score is only useful if you can act on it. For any drug in the plan, Drug-PIN shows a list of alternatives for the therapy, rescores the patient’s entire regimen with each substitution made, and reports the difference.

Rescored for this patient

The whole plan is recalculated, including every drug you left alone, so the figure shown is that patient’s, against their own genotype, kidney function and diagnoses.

What the difference means

A better projected score means Drug-PIN found fewer measurable conflicts. It does not mean the drug is better for this patient, and it does not account for what the record does not contain.

Comparable substances

The list covers therapeutically comparable substances for which Drug-PIN holds interaction data, so the comparison is like for like.

The replace-medication dialog in Drug-PIN. Simvastatin 20 mg is shown with the patient's total
           score of 220.00, above three of seven comparable substances: pravastatin 40 mg at 162.00,
           rosuvastatin 10 mg at 169.00 and atorvastatin 20 mg at 208.00, each with the difference it
           would make to the whole plan.
Replacing one drug, with the whole plan rescored.

The report

What the doctor keeps.

A final, locked PDF for the patient record, previewed in full before it is issued, then frozen, so later changes to data or templates cannot alter a document that has already been signed.

  • Patient data, laboratory values and clinical ratings
  • Predicted biochemical-functional phenotype
  • The medication list with the total score
  • Drug-class comparison for every medication

Issued as a short summary or the full document. The full version adds the score composition, the interaction list by severity, the kidney and PRISCUS recommendations, the metabolic analysis and the biochemical interaction matrix.

The report history for a patient in Drug-PIN. Four reports are listed by date, each with the
           total score at the time it was issued (220.00, 238.00, 251.00 and 196.00), and the
           name of the doctor who generated it. The patient is identified by a pseudonym and a
           generated patient number.
Every report kept, dated and attributed, and none of them editable afterwards.

Try it on a case you already know.

The quickest way to judge a score is to run a case where you already know the answer.

Request trial access